Cargando…
Structural and molecular basis of angiotensin-converting enzyme by computational modeling: Insights into the mechanisms of different inhibitors
Angiotensin-I converting enzyme (ACE) is a two-domain dipeptidylcarboxypeptidase involved in regulating blood pressure via the kallikrein-kininand renin-angiotensin-aldosterone complex. Therefore, ACE is a key drug target for the treatment of cardiovascular system diseases. At present many works are...
Autores principales: | Fang, Li, Geng, Mingxian, Liu, Chunlei, Wang, Ji, Min, Weihong, Liu, Jingsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472769/ https://www.ncbi.nlm.nih.gov/pubmed/30998765 http://dx.doi.org/10.1371/journal.pone.0215609 |
Ejemplares similares
-
Molecular Basis
for Omapatrilat and Sampatrilat Binding
to Neprilysin—Implications for Dual Inhibitor Design with Angiotensin-Converting
Enzyme
por: Sharma, Urvashi, et al.
Publicado: (2020) -
Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020) -
Mechanistic Insights into Angiotensin I-Converting
Enzyme Inhibitory Tripeptides to Decipher the Chemical Basis of Their
Activity
por: Lammi, Carmen, et al.
Publicado: (2022) -
Angiotensin-converting-enzyme inhibitor–induced angioedema
por: Quickfall, Danica, et al.
Publicado: (2021)